Structural Bioinformatics-Based Design of Selective, Irreversible Kinase Inhibitors
Citations Over TimeTop 1% of 2005 papers
Abstract
The active sites of 491 human protein kinase domains are highly conserved, which makes the design of selective inhibitors a formidable challenge. We used a structural bioinformatics approach to identify two selectivity filters, a threonine and a cysteine, at defined positions in the active site of p90 ribosomal protein S6 kinase (RSK). A fluoromethylketone inhibitor, designed to exploit both selectivity filters, potently and selectively inactivated RSK1 and RSK2 in mammalian cells. Kinases with only one selectivity filter were resistant to the inhibitor, yet they became sensitized after genetic introduction of the second selectivity filter. Thus, two amino acids that distinguish RSK from other protein kinases are sufficient to confer inhibitor sensitivity.
Related Papers
- → Influence of threonine exporters on threonine production in Escherichia coli(2002)91 cited
- → Unexpected increase in C5+ selectivity at temperature rise in high pressure Fischer-Tropsch synthesis over Co-Al2O3/SiO2 catalyst(2017)19 cited
- → Shape selectivity assessment of stationary phases in gas chromatography(1994)30 cited
- → Threonine Metabolism in Vivo: Effect of Threonine Intake and Prior Induction of Threonine Dehydratase in Rats(1978)71 cited
- → The Threonine Requirement of the Chick(1949)21 cited